BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34234563)

  • 1. What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations.
    Bossi P; Antonuzzo A; Armento G; Consoli F; Giuliani J; Giusti R; Lucchesi M; Mirabile A; Palermo L; Scagliarini S
    Cancer Manag Res; 2021; 13():5203-5210. PubMed ID: 34234563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.
    ; Vellucci R; Fanelli G; Pannuti R; Peruselli C; Adamo S; Alongi G; Amato F; Consoletti L; Lamarca L; Liguori S; Lo Presti C; Maione A; Mameli S; Marinangeli F; Marulli S; Minotti V; Miotti D; Montanari L; Moruzzi G; Palermo S; Parolini M; Poli P; Tirelli W; Valle A; Romualdi P
    Drugs; 2016 Mar; 76(3):315-30. PubMed ID: 26755179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usability, Acceptability, and Usefulness of an mHealth App for Diagnosing and Monitoring Patients With Breakthrough Cancer Pain.
    Boceta J; Samper D; de la Torre A; Sánchez-de la Rosa R; González G
    JMIR Cancer; 2019 Apr; 5(1):e10187. PubMed ID: 30932862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.
    Davies AN; Elsner F; Filbet MJ; Porta-Sales J; Ripamonti C; Santini D; Webber K
    BMJ Support Palliat Care; 2018 Sep; 8(3):241-249. PubMed ID: 29875184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 7. Practice Patterns in Distinguishing Between Background Pain and Breakthrough Pain During Patient Education: a Korean Physician Survey.
    Shin J; Kim DY; Lee J; Choi YS; Hwang IG; Baek SK; Seo MS; Shim JY
    J Cancer Educ; 2018 Apr; 33(2):284-292. PubMed ID: 27623849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.
    Alarcón MDL; Estévez FV; Cabezón-Gutiérrez L; Padrós MC; Martín-Arroyo JMT; Rebollo MA; Jiménez-López AJ; Sanz-Yagüe A
    J Geriatr Oncol; 2019 Jul; 10(4):643-652. PubMed ID: 31036463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.
    López López R; Camps Herrero C; Khosravi-Shahi P; Guillem Porta V; Carrato Mena A; Garcia-Foncillas J; Cruz Hernández JJ; Gascón Vilaplana P; Antón Torres A; Diaz-Rubio E; Feyjoo Saus M; Aranda Aguilar E
    Clin Transl Oncol; 2018 May; 20(5):613-618. PubMed ID: 28975575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
    Boceta J; De la Torre A; Samper D; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2016 Nov; 18(11):1088-1097. PubMed ID: 26856600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough cancer pain: The importance of the right treatment at the right time.
    O'Hagan P; Mercadante S
    Eur J Pain; 2018 Aug; 22(7):1362-1374. PubMed ID: 29635732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts.
    Camps Herrero C; Antón Torres A; Cruz-Hernández JJ; Carrato A; Constenla M; Díaz-Rubio E; Feyjoo Saus M; Garcia-Foncillas J; Gascón P; Guillem V
    J Pain Res; 2019; 12():2349-2358. PubMed ID: 31534359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough cancer pain: review and calls to action to improve its management.
    Camps Herrero C; Batista N; Díaz Fernández N; Escobar Álvarez Y; Gonzalo Gómez A; Isla Casado D; Salud A; Terrasa Pons J; Guillem Porta V
    Clin Transl Oncol; 2020 Aug; 22(8):1216-1226. PubMed ID: 32002739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).
    Porta-Sales J; Pérez C; Escobar Y; Martínez V
    Clin Transl Oncol; 2016 Sep; 18(9):945-54. PubMed ID: 26693731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough cancer pain (BTcP): a synthesis of taxonomy, pathogenesis, therapy, and good clinical practice in adult patients in Italy.
    Zucco F; Bonezzi C; Fornasari D
    Adv Ther; 2014 Jul; 31(7):657-82. PubMed ID: 25005168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain.
    Ferrer Albiach C; Villegas Estévez F; López Alarcón MD; de Madariaga M; Carregal A; Arranz J; Trinidad Martín-Arroyo JM; Jiménez López AJ; Sanz Yagüe A
    J Pain Res; 2019; 12():2125-2135. PubMed ID: 31372030
    [No Abstract]   [Full Text] [Related]  

  • 19. Breakthrough Cancer Pain: Ten Commandments.
    Mercadante S; Cuomo A
    Value Health; 2016; 19(5):531-6. PubMed ID: 27565269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group.
    Mercadante S; Marchetti P; Cuomo A; Mammucari M; Caraceni A;
    Support Care Cancer; 2016 Feb; 24(2):961-968. PubMed ID: 26438145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.